How do you pay?

How to pay the least

Ask for the cash price

Zymfentra

Zymfentra is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Zymfentra’s cash price, and one or two other pharmacies too.
  2. Zymfentra’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameZymfentra
Authorized genericinfliximab-dyyb
Regular genericinfliximab-dyyb
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Zymfentra?
The original
–
–

Brand nameThe maker’s card

Celltrion CARES Co-pay Assistance Program

Savings card from Celltrion

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

Sign up on celltrionconnect.com 

In the maker’s words

“Patients may pay as little as $0 for each dose of ZYMFENTRA…”

From the maker’s offer on celltrionconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Zymfentra itself, from the same company, sold without the brand name, and usually for less. For now Zymfentra is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Zymfentra is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ZYMFENTRA is a tumor necrosis factor (TNF) blocker indicated in adults for maintenance treatment of:

  • moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously.
  • moderately to severely active Crohn’s disease following with an infliximab products administered intraneously.

Source: the FDA label for Zymfentra (CELLTRION USA Inc.), August 18, 2026. Full label on DailyMed 

Good to know